Author: kaiser

Senior Principal Research Scientist, Abbvie, USA “Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis”

University of Heidelberg “Microfluidic “organ-on-a-chip” tissue culture model systems for drug testing and toxicity studies”

Medicines for Malaria Venture “Replenishing the malaria drug discovery pipeline: Advances in Hit Generation for Antimalarial Drug Discovery”

Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee “The direct approach: the role of chemical proteomics in drug target deconvolution”

University of Nebraska “Optimization of Neurolysin Activators as Potential Therapeutic Options in Ischemic Stroke”

Drug Discovery Unit, University of Dundee “DMPK Challenges and Opportunities in Malaria Drug Discovery”

AM, FTSE – Griffith University “Approaches for Natural Product Drug Discovery from compound libraries to Hit Identification”

Deputy DirectorEU-OPENSCREEN ERIC “Putting your compounds to good use: EU-OPENSCREEN’s open compound sharing initiative”